换一批
换一批Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial.
作者：
主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);硼酸化物(Boronic Acids);无病生存(Disease-Free Survival);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);美法仑(Melphalan);多发性骨髓瘤(Multiple Myeloma);泼尼松(Prednisone);比例危险度模型(Proportional Hazards Models);吡嗪类(Pyrazines);沙立度胺(Thalidomide);治疗结果(Treatment Outcome)
DOI
10.1200/JCO.2010.29.8216
PMID
20940200
发布时间
2022-03-10
- 浏览211
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
